CN118829422A - 三峰、精确定时的释放片剂 - Google Patents

三峰、精确定时的释放片剂 Download PDF

Info

Publication number
CN118829422A
CN118829422A CN202380021979.8A CN202380021979A CN118829422A CN 118829422 A CN118829422 A CN 118829422A CN 202380021979 A CN202380021979 A CN 202380021979A CN 118829422 A CN118829422 A CN 118829422A
Authority
CN
China
Prior art keywords
tablet
buspirone
release
release component
patient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202380021979.8A
Other languages
English (en)
Chinese (zh)
Inventor
M·布拉姆斯
A·斯特劳恩
S·谢弗
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cingulate Therapeutics LLC
Original Assignee
Cingulate Therapeutics LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cingulate Therapeutics LLC filed Critical Cingulate Therapeutics LLC
Publication of CN118829422A publication Critical patent/CN118829422A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN202380021979.8A 2022-02-16 2023-02-15 三峰、精确定时的释放片剂 Pending CN118829422A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263310677P 2022-02-16 2022-02-16
US63/310,677 2022-02-16
PCT/US2023/013139 WO2023158694A1 (en) 2022-02-16 2023-02-15 Trimodal, precision-timed release tablet

Publications (1)

Publication Number Publication Date
CN118829422A true CN118829422A (zh) 2024-10-22

Family

ID=87579044

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202380021979.8A Pending CN118829422A (zh) 2022-02-16 2023-02-15 三峰、精确定时的释放片剂

Country Status (9)

Country Link
US (1) US20250177310A1 (enExample)
EP (1) EP4479028A4 (enExample)
JP (1) JP2025505781A (enExample)
KR (1) KR20240150485A (enExample)
CN (1) CN118829422A (enExample)
AU (1) AU2023222759A1 (enExample)
CA (1) CA3252172A1 (enExample)
IL (1) IL314820A (enExample)
WO (1) WO2023158694A1 (enExample)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8704097D0 (sv) * 1987-10-22 1987-10-22 Astra Ab Oral formulation of buspirone and salts thereof
US20090297597A1 (en) * 1998-11-02 2009-12-03 Gary Liversidge Modified Release Ticlopidine Compositions
JP2002541092A (ja) * 1999-04-06 2002-12-03 ファーマクエスト・リミテッド メチルフェニデートのパルス性送達のための薬学的投薬形態
CN100551373C (zh) * 2005-12-01 2009-10-21 北京华素制药股份有限公司 盐酸丁螺环酮缓/控释微丸
EP1970055B1 (en) * 2005-12-29 2010-11-24 Osmotica Kereskedelmi És Szolgáltató Kft Multi-layered tablet with triple release combination
PT2838517T (pt) * 2012-04-18 2018-01-04 Contera Pharma Aps Formulação farmacêutica disponível sob forma oral adequada para a melhoria da gestão dos distúrbios da mobilidade
JP2018506590A (ja) * 2015-02-27 2018-03-08 シンギュレイト・セラピューティクス・リミテッド・ライアビリティ・カンパニーＣｉｎｇｕｌａｔｅ Ｔｈｅｒａｐｅｕｔｉｃｓ ＬＬＣ トリパルス放出型賦活薬製剤

Also Published As

Publication number Publication date
EP4479028A1 (en) 2024-12-25
WO2023158694A1 (en) 2023-08-24
KR20240150485A (ko) 2024-10-15
IL314820A (en) 2024-10-01
EP4479028A4 (en) 2026-02-25
US20250177310A1 (en) 2025-06-05
CA3252172A1 (en) 2023-08-24
JP2025505781A (ja) 2025-02-28
AU2023222759A1 (en) 2024-09-12

Similar Documents

Publication Publication Date Title
EP1755561B1 (en) Multi-layer tablet comprising non-steroidal anti-inflammatory drugs decongestants and non-sedating antihistamines
US20090023744A1 (en) Combination therapy for depression
US20250049722A1 (en) Tripulse release stimulant formulations
JP2007530620A (ja) メロキシカムを含む組成物
US20030228359A1 (en) Pharmaceutical formulations containing epinastine, belladonna, and pseudoephedrine
US20250177310A1 (en) Trimodal, precision-timed release tablet
WO2024139978A1 (zh) Vofopitant用于治疗肺纤维化的用途
US20050084527A1 (en) Pharmaceutical formulations containing combinations of epinastine, pseudoephedrine, and methylephedrine
US20050171119A1 (en) Pharmaceutical formulations with modified release
EP4337169B1 (en) Trimodal, precision-timed pulsatile release tablet
RU2819722C2 (ru) Применение 1-(2-(1н-имидазол-4-ил)этил)пиперидин-2,6-диона для лечения кашля, вызванного вирусными инфекциями
CZ2003945A3 (cs) Farmaceutický prostředek
WO2005007145A1 (en) Pharmaceutical product comprising a beta-2 adrenoceptor agonist and an antihistamine
HK40108332B (en) Trimodal, precision-timed pulsatile release tablet
HK40108332A (en) Trimodal, precision-timed pulsatile release tablet
US20240082176A1 (en) Dropropizine in combination with ambroxol in the dosage form of syrup and tablets

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination